PF-Atlas › Clinical Trials › NCT04658277
Effect of Long Term Clarithromycin for Prevention of Exacerbations in Non-cystic Fibrosis Bronchiectasis in Asian Populations
Clarithromycin · Not specified
Registry ID
NCT04658277
Phase
Not specified
Status
Unknown
Drug / intervention
Clarithromycin
Sponsor
Chinese University of Hong Kong
Start
2020-10-01
About this trial
Clarithromycin is evaluated in NCT04658277, a idiopathic pulmonary fibrosis study sponsored by Chinese University of Hong Kong. Current status: Unknown.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04658277 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.